Researchers developed an AI tool to standardize PD-L1 scoring in lung cancer, reducing variability and flagging borderline ...
The Phase 2 study (NCT06954467) aiming to evaluate the safety and efficacy of JS207 in combination with JS007 included a safety run-in period and a randomized expansion phase, which enrolled patients ...
PD-1 inhibitors may raise heart failure risk in patients with prior ischaemia. Discover key findings and clinical ...
The Chosun Ilbo on MSN
Immune checkpoint inhibitors revolutionize cancer treatment
Mr. Kim, 62 years old, a man preparing for retirement, was an office worker diligently attending to his job just a year ago.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results